Clinical significance of white-coat hypertension

Journal of Hypertension

Volumn 34, Issue 4, 2016, Pages 623-626

  Mancia, Giuseppe ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; TRIACYLGLYCEROL;

CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; HUMAN; INCIDENCE; NOTE; PRIORITY JOURNAL; PROGNOSTIC ASSESSMENT; SCIENTIFIC LITERATURE; WHITE COAT HYPERTENSION; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; HYPERTENSION;

BLOOD PRESSURE DETERMINATION; BLOOD PRESSURE MONITORING, AMBULATORY; HUMANS; HYPERTENSION; WHITE COAT HYPERTENSION;

EID: 84960445539     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000879     Document Type: Note

References (17)

1. Briasoulis A, Androulakis E, Palla M, Papageorgiou N, Tousoulis D. White-coat hypertension and cardiovascular events: a meta-Analysis. J Hypertens 2016; 34:593-599.
2. Mancia G, Bombelli M, Sega R, Grassi G. White coat and masked hypertension, Chapter 7. In: Black HR, Elliott WJ, editors. Hypertension: a companion to Braunwalds heart disease. Elsevier; 2012; 64-68.
3. Tientcheu D, Ayers C, Das SR, McGuire DK, de Lemos JA, Khera A, et al. Target organ complications and cardiovascular events associated with masked hypertension and white-coat hypertension: analysis from the Dallas Heart Study. J Am Coll Cardiol 2015; 66:2159-2169.
4. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2013 ESH/ESC Guidelines for the management of arterial hypertension. J Hypertens 2013; 31:1281-1357.
5. Cuspidi C, Rescaldani M, Tadic M, Sala C, Grassi G, Mancia G. Whitecoat hypertension, as defined by ambulatory blood pressure monitoring, and subclinical cardiac organ damage: a meta-Analysis. J Hypertens 2015; 33:24-32.
6. Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long-Term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension 2006; 47:846-853.
7. Mancia G, Verdecchia P. Clinical value of ambulatory blood pressure: evidence and limits. Circ Res 2015; 116:1034-1045.
8. Mancia G, Bombelli M, Facchetti R, Madotto F, Quarti-Trevano F, Grassi G, Sega R. Increased long-Term risk of new-onset diabetes mellitus in white-coat and masked hypertension. J Hypertens 2009; 27:1672-1678.
9. Mancia G, Bombelli M, Facchetti R, Madotto F, Quarti-Trevano F, Polo Friz H, et al. Long-Term risk of sustained hypertension in white-coat or masked hypertension. Hypertension 2009; 54:226-232.
10. National Institiute for Health and Clinical Exellence (NICE). Hypertension. The clinical management of primary hypertension in adults. Clinical (Accessed August 2011) Guideline 127; www.nice.org.uk/ guidance/CG127.
11. Mancia G, Facchetti R, Grassi G, Bombelli M. Adverse prognostic value of persistent office blood pressure elevation in white-coat hypertension. J Hypertens 2015; 66:437-444.
12. Mancia G, Bombelli M, Brambilla G, Facchetti R, Sega R, Toso E, Grassi G. Long-Term prognostic value of white coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements. Hypertension 2013; 62:168-174.
13. Mancia G, Facchetti R, Parati G, Zanchetti A. Effect of long-Term antihypertensive treatment on white-coat hypertension. Hypertension 2014; 64:1388-1398.
14. Fagard RH, Staessen JA, Thijs L, Gasowski J, Bulpitt CJ, Clement D, et al. Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation 2000; 102:1139-1144.
15. MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party. Br Med J (Clin Res Ed) 1985; 291:97-104.
16. Five-year findings of the hypertension detection and follow-up program. III. Reduction in stroke incidence among persons with high blood pressure. Hypertension Detection and Follow-up Program Cooperative Group. JAMA 1982; 247:633-638.
17. Bulpitt CJ, Beckett N, Peters R, Staessen JA, Wang JG, Comsa M, et al. Does white coat hypertension require treatment over age 80? Results of the hypertension in the very elderly trial ambulatory blood pressure side project. Hypertension 2013; 61:89-94.